Skip to main navigation Skip to search Skip to main content

Assessing the impact of long-acting injectable compared to oral antipsychotic medications on readmission to a state psychiatric hospital

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

What is known on the subject: People living with schizophrenia spectrum disorder (SSD) have a higher death rate which is caused, in part, by poorer adherence to treatment as compared to those with other mental illnesses. Using long-acting injectable antipsychotic (LAI) medications can improve medication adherence and reduce hospitalizations for people living with SSD but are often underutilized. What the paper adds to existing knowledge: As compared to oral antipsychotic medications provided to patients with SSD at discharge from a psychiatric hospitalization, being provided with an LAI antipsychotic medication may reduce subsequent rehospitalization. Specifically, patients discharged on an atypical or second-generation LAI medication are less likely to be readmitted to the hospital when compared to those discharged on a typical first-generation oral medication. What are the implications for practice: Because LAI antipsychotic medications are often underutilized as treatment options, the study findings suggest that this modality may be considered for patients with SSD when being discharged from a psychiatric hospitalization. Ideally, psychiatric-mental health nurses can educate patients about indications, benefits, and risks of using atypical or second-generation LAI antipsychotic medications during hospitalization and at discharge prevent the risk for future rehospitalizations. Abstract: Introduction: People living with schizophrenia spectrum disorder (SSD) have poorer medication adherence compared to those with other mental illnesses. Long-acting injectable antipsychotic (LAI) medication use is associated with greater adherence, reduced re-hospitalizations, and improved recovery outcomes when compared to oral formulations. Aim: To compare LAI antipsychotic medication use versus oral formulations on readmission to an inpatient hospital. Method: Medical records (N = 707) from a state psychiatric hospital in the southern region of the United States were reviewed. Controlling for demographic variables, logistic regression analyses were used to examine LAI compared to oral formulations on readmission. Results: Compared to patients discharged with oral antipsychotic medications, those with LAIs had a lower proportion of readmission rates in 6-month and 1-year periods, but not 30-day or 2-year periods. When controlling for demographic variables, those discharged with an atypical LAI had significantly lower odds of being readmitted within the 24-year period compared to those discharged on a typical oral antipsychotic. Discussion: Compared to orals, LAIs do not increase and may mitigate readmissions to psychiatric hospitalization. Implications for Practice: Psychiatric-mental health nurses and other professionals may recommend LAIs when indicated for those with SSD.

Original languageEnglish
Pages (from-to)1155-1163
Number of pages9
JournalJournal of Psychiatric and Mental Health Nursing
Volume31
Issue number6
DOIs
StatePublished - Dec 2024

Bibliographical note

Publisher Copyright:
© 2024 John Wiley & Sons Ltd.

Funding

Research reported in this publication was supported, in part, by the Cabinet for Health and Family Services, Department for Medicaid Services under Agreement titled \u201CAssessing the Impact of Long-Acting Injectables on Psychiatric Treatment Outcomes among Medicaid Beneficiaries.\u201D

Funders
Department for Public Health, Cabinet for Health and Family Services
KY Department for Medicaid Services

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • discharge
    • long-acting injectable antipsychotic
    • psychiatric hospitalization
    • psychiatric-mental health nursing
    • readmission
    • schizophrenia

    ASJC Scopus subject areas

    • Psychiatric Mental Health

    Fingerprint

    Dive into the research topics of 'Assessing the impact of long-acting injectable compared to oral antipsychotic medications on readmission to a state psychiatric hospital'. Together they form a unique fingerprint.

    Cite this